Impaired
insulin-stimulated
glycogen synthesis of peripheral tissues is a characteristic feature of many patients with
non-insulin-dependent diabetes mellitus (
NIDDM) and their first-degree relatives with normal
glucose tolerance, suggesting putative inherited defects in this metabolic pathway. In previous studies, we have failed to reveal mutations in the coding regions of the muscle-specific
glycogen synthase gene and the three genes that encode the catalytic subunits of
protein phosphatase 1 (PP1) as frequent causes of
insulin resistance. Because the
glycogen-associated regulatory subunit of
protein phosphatase 1 (PP1 G-subunit) plays a key role in the
insulin stimulation of
glycogen synthesis and the activity of PP1 is decreased in
insulin-resistant subjects, we have now cloned the human G-subunit
cDNA to search for abnormalities in the corresponding gene (designated PPP1R3 in the human genome nomenclature) in patients with
NIDDM. The human
cDNA was isolated from a skeletal muscle cDNA library and was found to encode a 126-kDa
protein, which shows 73%
amino acid identity to the rabbit PP1 G-subunit. The human G-subunit
cDNA from 30
insulin-resistant
NIDDM patients was analyzed for genetic variations in the G-subunit by using single-stranded conformation polymorphism (SSCP) scanning of reversely transcribed
mRNA. One variant SSCP profile was detected in the region encoding the COOH-terminal part of the PP1 G-subunit in only one
NIDDM patient, and subsequent
nucleotide sequencing showed a C to A transversion on one allele at base position 2792. This change predicts an amino acid substitution from
alanine to
glutamic acid.(ABSTRACT TRUNCATED AT 250 WORDS)